Down-regulation of Bcl-2 in rat substantia nigra after focal cerebral ischemia

NeuroReport

Volumn 15, Issue 9, 2004, Pages 1437-1441

  Arango Dávila, Cesar A ^a   Cardona Gomez, Gloria P ^b,d   Gallego Gomez, Juan C ^b,c   Garcia Segura, Luis M ^d   Pimienta, Hernán J ^a  

^a UNIVERSIDAD DEL VALLE   (Colombia)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c CSIC   (Spain)

^d INSTITUTO CAJAL   (Spain)

Author keywords

Apoptosis; Bcl 2; Exo focal; Ischemia; NeuN; Neuronal death; Substantia nigra

Indexed keywords

PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL LOSS; CELL NUCLEUS; CONTROLLED STUDY; DOWN REGULATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RAT; SUBSTANTIA NIGRA;

ANIMALS; BRAIN ISCHEMIA; CELL DEATH; DOWN-REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEURONS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; SUBSTANTIA NIGRA;

EID: 3142734875     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000131010.74494.75     Document Type: Article

References (24)

1. Hara H, Harada K and Sukamoto T. Chronological atrophy after transient middle cerebral artery occlusion in rats. Brain Res 1993; 2:251-260.
2. Kinouchi H, Sharp FR, Chan PH, Koistinaho J, Sagar SM and Yoshimoto T. Induction of c-fos, junB, c-jun, and hsp70 mRNA in cortex, thalamus basal ganglia, and hippocampus following middle cerebral artery occlusion. J Cerebr Blood Flow Metab 1994; 5:808-817.
3. Zhao F, Kuroiwa T, Miyasaka N, Nagaoka T, Nakane M, Tamura A and Mizusawa H. Ultrastructural and MRI study of the substantia nigra evolving exofocal post-ischemic neuronal death in the rat. Neuropathology 2002; 3:91-105.
4. DeGiorgio LA, Dibinis C, Milner TA, Saji M and Volpe BT. Histological and temporal characteristics of nigral transneuronal degeneration after striatal injury. Brain Res 1998; 795:1-9.
5. 3H]inositol 1,4,5-trisphosphate binding using autoradiography in the exo-focal post-ischemic brain areas of the rat. J Neurosci Res 1992; 3:507-512.
6. Nagasawa H, Araki T and Kogure K. Autoradiographic analysis of second-messenger and neurotransmitter receptor system in the exo-focal remote areas of post-ischemic rat brain. Brain Res Bull 1994; 35:347-352.
7. Goto S, Yamada K, Inoue N, Nagahiro S and Ushio Y. Increased expression of growth-associated protein GAP-43/B-50 following cerebral hemitransection or striatal ischemic injury in the substantia nigra of adult rats. Brain Res 1994; 2:333-339.
8. Yamada K, Goto S, Yoshikawa M and Ushio Y. Gabaergic transmission and tyrosine hydroxylase expression in the nigral dopaminergic neurons: an in vivo study using a reversible ischemia model of rats. Neuroscience 1996; 3:783-789.
9. Cory S and Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nature Rev Cancer 2002; 2:647-656.
10. Gillardon F, Lenz C, Waschke KF, Krajewski S, Reed JC, Zimmermann M and Kuschinsky W. Altered expression of Bcl-2, Bcl-X, Bax, and c-Fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats. Brain Res Mol Brain Res 1996; 2:254-260.
11. Kroemer G, Petit P, Zamzami N, Vayssiere JL and Mignotte B. The biochemistry of programmed cell death. FASEB J 1995; 13:1277-1287.
12. Banasiak KJ, Xia Y and Haddad GG. Mechanisms underlying hypoxia-induced neuronal apoptosis. Prog Neurobiol 2000; 3:215-249.
13. Longa EZ, Wenstein PR, Carlson S and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20:84-91.
14. Belayev L, Busto R, Zhao W, Fernandez G and Ginsberg MD. Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-L-lysine: neurological and histological validation. Brain Res 1999; 2:181-190.
15. Shao W, Belayeb L and Ginsberg M. Transient middle cerebral artery occlusion by intraluminal suture: II. Neurological deficit, and pixel-based correlation of histopathology with local blood flow and glucose utilization. J Cerebr Blood Flow Metab 1997; 12:1281-1290.
16. Li G, Farooque M, Lennmyr F, Holtz A and Olsson Y. MAP2 and neurogranin as markers for dendritic lesion in CNS injury. On immunohistochemical study in rat. APMIS 2000; 108:298-206.
17. Saji M, Kimura M, Ishida G and Ohno K. Deafferentiation-induced c-fos gene expression in subthalamic nucleus and substantia nigra reticulata is reduced by non-NMDA receptor antagonist. Brain Res 1995; 1-2:165-174.
18. Saji M, Endo Y, Miyanishi T, Volpe BT and Ohno K. Behavioral correlates of transneuronal degeneration of substantia nigra reticulata neurons are reversed by ablation of the subthalamic nucleus. Behav Brain Res 1997; 1-2:63-71.
19. Winter C, Weiss C, Martin-Villalba A, Zimmermann M and Schenkel J. JunB and Bcl-2 overexpression results in protection against cell death of nigral neurons following axotomy. Brain Res Mol Brain Res 2002; 104:194-202.
20. Chuang JI and Chen ST. Differential expression of Bcl-2 and APP immunoreactivity after intrastriatal injection of MPP + in the rat. Neurochem Int 2002; 40:169-179.
21. Nakayama H, Tamura A, Kanazawa I and Sano K. Time-sequential change of amino acid neurotransmitters-GABA, aspartate and glutamaten the rat basal ganglia following middle cerebral artery occlusion. Neurol Res 1990; 4:231-235.
22. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA and Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995; 4:961-973.
23. Garcia-Galloway E, Arango C, Pons S and Torres-Aleman I. Glutamate excitotoxicity attenuates insulin-like growth factor-I prosurvival signaling. Mol Cell Neurosci 2003; 24:1027-1037.
24. Jabs R, Bekar L, Walz W. Reactive astrogliosis in the injured and post-ischemic brain. In: Walz W (ed.). Cerebral Ischemia: Molecular and Cellular Pathophysiology. Totowa, NJ: Humana Press Inc; 1999, pp. 233-249.